Targeting of Monomer/Misfolded SOD1 as a Therapeutic Strategy for Amyotrophic Lateral Sclerosis

There is increasing evidence that toxicity of mutant superoxide dismutase-1 (SOD1) in amyotrophic lateral sclerosis (ALS) is linked to its propensity to misfold and to aggregate. Immunotargeting of differently folded states of SOD1 has provided therapeutic benefit in mutant SOD1 transgenic mice. The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci
Main Authors: Liu, Hsueh-Ning, Tjostheim, Sonja, DaSilva, Kevin, Taylor, David, Zhao, Beibei, Rakhit, Rishi, Brown, Mary, Chakrabartty, Avijit, McLaurin, JoAnne, Robertson, Janice
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6622344/
https://ncbi.nlm.nih.gov/pubmed/22745481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.5053-11.2012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados